Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention in Adolescents and Young Adults

Purpose of Review To review the literature about oral pre-exposure prophylaxis (PrEP) for HIV prevention, with specific focus on adolescents. Recent Findings Use of PrEP reduces new HIV infections among men who have sex with men, heterosexuals, and people who inject drugs. One combination antiretrov...

Full description

Saved in:
Bibliographic Details
Published in:Current pediatrics reports (Philadelphia, PA) PA), 2018-06, Vol.6 (2), p.114-122
Main Authors: Mullins, Tanya L. Kowalczyk, Lehmann, Corinne E.
Format: Article
Language:English
Subjects:
Adolescent Medicine (M Goldstein and L Johnson
Medicine
Medicine & Public Health
Pediatrics
Section Editors
Topical Collection on Adolescent Medicine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c357x-3e44826e6aa6d4d76c87152434c2edcf65e6a6f2fa89d9c9afcafb299ebb2cc13
cites cdi_FETCH-LOGICAL-c357x-3e44826e6aa6d4d76c87152434c2edcf65e6a6f2fa89d9c9afcafb299ebb2cc13
container_end_page 122
container_issue 2
container_start_page 114
container_title Current pediatrics reports (Philadelphia, PA)
container_volume 6
creator Mullins, Tanya L. Kowalczyk
Lehmann, Corinne E.
description Purpose of Review To review the literature about oral pre-exposure prophylaxis (PrEP) for HIV prevention, with specific focus on adolescents. Recent Findings Use of PrEP reduces new HIV infections among men who have sex with men, heterosexuals, and people who inject drugs. One combination antiretroviral medication is approved for PrEP in the USA for adults. Limited data suggest that PrEP is safe for use in youth, although declines in adherence to PrEP over time suggest the need for adherence interventions specifically targeting youth. Safety concerns related to PrEP include potential negative impacts on bone density and renal function, as well as potential increases in riskier sexual behaviors. The U.S. Public Health Service has published guidelines for PrEP use in adults. Summary Current data suggest that PrEP use is safe in adolescents; however, further research is needed on the potential impact of long-term PrEP use on bone density and kidney function.
doi_str_mv 10.1007/s40124-018-0163-x
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6192052</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2125295809</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357x-3e44826e6aa6d4d76c87152434c2edcf65e6a6f2fa89d9c9afcafb299ebb2cc13</originalsourceid><addsrcrecordid>eNp9UU1rAjEQDaWlivUH9FL2aA_bJtlsdvdSkGKrIOihH_QUYjarK2tiE1fWf98RrdhLAyGTmfdeZvIQuiX4gWCcPHqGCWUhJilsHoXNBWpTwpOQpYxcnsUt1PV-iWGlwOPRNWpFOGIxkNroc-JkFUydDnWztr52Gi52vdhVsil90Ju6wfQ-KKwLhqOPPW6rzaa0JihN0M9tpb2ChA-kyYMvW5s5ZOtq42_QVSErr7vHs4PeXwZvz8NwPHkdPffHoYripAkjzVhKueZS8pzlCVdpQmLKIqaozlXBYyjxghYyzfJMZbJQspjRLNOzGVWKRB30dNBd17MVMKAZGEisXbmSbiesLMXfiikXYm63gpOM4piCQO8o4Ox3rf1GrEqYqaqk0bb2ghIa0yxOcQZQcoAqZ713ujg9Q7DYeyIOngjwROw9EQ1w7s77OzF-HQAAPQA8lMxcO7G0tTPwZ_-o_gAs85kI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2125295809</pqid></control><display><type>article</type><title>Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention in Adolescents and Young Adults</title><source>Springer Nature</source><creator>Mullins, Tanya L. Kowalczyk ; Lehmann, Corinne E.</creator><creatorcontrib>Mullins, Tanya L. Kowalczyk ; Lehmann, Corinne E.</creatorcontrib><description>Purpose of Review To review the literature about oral pre-exposure prophylaxis (PrEP) for HIV prevention, with specific focus on adolescents. Recent Findings Use of PrEP reduces new HIV infections among men who have sex with men, heterosexuals, and people who inject drugs. One combination antiretroviral medication is approved for PrEP in the USA for adults. Limited data suggest that PrEP is safe for use in youth, although declines in adherence to PrEP over time suggest the need for adherence interventions specifically targeting youth. Safety concerns related to PrEP include potential negative impacts on bone density and renal function, as well as potential increases in riskier sexual behaviors. The U.S. Public Health Service has published guidelines for PrEP use in adults. Summary Current data suggest that PrEP use is safe in adolescents; however, further research is needed on the potential impact of long-term PrEP use on bone density and kidney function.</description><identifier>ISSN: 2167-4841</identifier><identifier>EISSN: 2167-4841</identifier><identifier>DOI: 10.1007/s40124-018-0163-x</identifier><identifier>PMID: 30345163</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adolescent Medicine (M Goldstein and L Johnson ; Medicine ; Medicine &amp; Public Health ; Pediatrics ; Section Editors ; Topical Collection on Adolescent Medicine</subject><ispartof>Current pediatrics reports (Philadelphia, PA), 2018-06, Vol.6 (2), p.114-122</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357x-3e44826e6aa6d4d76c87152434c2edcf65e6a6f2fa89d9c9afcafb299ebb2cc13</citedby><cites>FETCH-LOGICAL-c357x-3e44826e6aa6d4d76c87152434c2edcf65e6a6f2fa89d9c9afcafb299ebb2cc13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30345163$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mullins, Tanya L. Kowalczyk</creatorcontrib><creatorcontrib>Lehmann, Corinne E.</creatorcontrib><title>Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention in Adolescents and Young Adults</title><title>Current pediatrics reports (Philadelphia, PA)</title><addtitle>Curr Pediatr Rep</addtitle><addtitle>Curr Pediatr Rep</addtitle><description>Purpose of Review To review the literature about oral pre-exposure prophylaxis (PrEP) for HIV prevention, with specific focus on adolescents. Recent Findings Use of PrEP reduces new HIV infections among men who have sex with men, heterosexuals, and people who inject drugs. One combination antiretroviral medication is approved for PrEP in the USA for adults. Limited data suggest that PrEP is safe for use in youth, although declines in adherence to PrEP over time suggest the need for adherence interventions specifically targeting youth. Safety concerns related to PrEP include potential negative impacts on bone density and renal function, as well as potential increases in riskier sexual behaviors. The U.S. Public Health Service has published guidelines for PrEP use in adults. Summary Current data suggest that PrEP use is safe in adolescents; however, further research is needed on the potential impact of long-term PrEP use on bone density and kidney function.</description><subject>Adolescent Medicine (M Goldstein and L Johnson</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Pediatrics</subject><subject>Section Editors</subject><subject>Topical Collection on Adolescent Medicine</subject><issn>2167-4841</issn><issn>2167-4841</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9UU1rAjEQDaWlivUH9FL2aA_bJtlsdvdSkGKrIOihH_QUYjarK2tiE1fWf98RrdhLAyGTmfdeZvIQuiX4gWCcPHqGCWUhJilsHoXNBWpTwpOQpYxcnsUt1PV-iWGlwOPRNWpFOGIxkNroc-JkFUydDnWztr52Gi52vdhVsil90Ju6wfQ-KKwLhqOPPW6rzaa0JihN0M9tpb2ChA-kyYMvW5s5ZOtq42_QVSErr7vHs4PeXwZvz8NwPHkdPffHoYripAkjzVhKueZS8pzlCVdpQmLKIqaozlXBYyjxghYyzfJMZbJQspjRLNOzGVWKRB30dNBd17MVMKAZGEisXbmSbiesLMXfiikXYm63gpOM4piCQO8o4Ox3rf1GrEqYqaqk0bb2ghIa0yxOcQZQcoAqZ713ujg9Q7DYeyIOngjwROw9EQ1w7s77OzF-HQAAPQA8lMxcO7G0tTPwZ_-o_gAs85kI</recordid><startdate>20180601</startdate><enddate>20180601</enddate><creator>Mullins, Tanya L. Kowalczyk</creator><creator>Lehmann, Corinne E.</creator><general>Springer US</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180601</creationdate><title>Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention in Adolescents and Young Adults</title><author>Mullins, Tanya L. Kowalczyk ; Lehmann, Corinne E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357x-3e44826e6aa6d4d76c87152434c2edcf65e6a6f2fa89d9c9afcafb299ebb2cc13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adolescent Medicine (M Goldstein and L Johnson</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Pediatrics</topic><topic>Section Editors</topic><topic>Topical Collection on Adolescent Medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mullins, Tanya L. Kowalczyk</creatorcontrib><creatorcontrib>Lehmann, Corinne E.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current pediatrics reports (Philadelphia, PA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mullins, Tanya L. Kowalczyk</au><au>Lehmann, Corinne E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention in Adolescents and Young Adults</atitle><jtitle>Current pediatrics reports (Philadelphia, PA)</jtitle><stitle>Curr Pediatr Rep</stitle><addtitle>Curr Pediatr Rep</addtitle><date>2018-06-01</date><risdate>2018</risdate><volume>6</volume><issue>2</issue><spage>114</spage><epage>122</epage><pages>114-122</pages><issn>2167-4841</issn><eissn>2167-4841</eissn><abstract>Purpose of Review To review the literature about oral pre-exposure prophylaxis (PrEP) for HIV prevention, with specific focus on adolescents. Recent Findings Use of PrEP reduces new HIV infections among men who have sex with men, heterosexuals, and people who inject drugs. One combination antiretroviral medication is approved for PrEP in the USA for adults. Limited data suggest that PrEP is safe for use in youth, although declines in adherence to PrEP over time suggest the need for adherence interventions specifically targeting youth. Safety concerns related to PrEP include potential negative impacts on bone density and renal function, as well as potential increases in riskier sexual behaviors. The U.S. Public Health Service has published guidelines for PrEP use in adults. Summary Current data suggest that PrEP use is safe in adolescents; however, further research is needed on the potential impact of long-term PrEP use on bone density and kidney function.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>30345163</pmid><doi>10.1007/s40124-018-0163-x</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2167-4841
ispartof Current pediatrics reports (Philadelphia, PA), 2018-06, Vol.6 (2), p.114-122
issn 2167-4841
2167-4841
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6192052
source Springer Nature
subjects Adolescent Medicine (M Goldstein and L Johnson
Medicine
Medicine & Public Health
Pediatrics
Section Editors
Topical Collection on Adolescent Medicine
title Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention in Adolescents and Young Adults
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T15%3A35%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20Pre-exposure%20Prophylaxis%20(PrEP)%20for%20HIV%20Prevention%20in%20Adolescents%20and%20Young%20Adults&rft.jtitle=Current%20pediatrics%20reports%20(Philadelphia,%20PA)&rft.au=Mullins,%20Tanya%20L.%20Kowalczyk&rft.date=2018-06-01&rft.volume=6&rft.issue=2&rft.spage=114&rft.epage=122&rft.pages=114-122&rft.issn=2167-4841&rft.eissn=2167-4841&rft_id=info:doi/10.1007/s40124-018-0163-x&rft_dat=%3Cproquest_pubme%3E2125295809%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c357x-3e44826e6aa6d4d76c87152434c2edcf65e6a6f2fa89d9c9afcafb299ebb2cc13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2125295809&rft_id=info:pmid/30345163&rfr_iscdi=true